sulfinpyrazone has been researched along with Nephrosis in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, T | 1 |
| Yagi, N | 1 |
| Yamahata, K | 1 |
| Ohnishi, M | 1 |
| Kadowaki, J | 1 |
| Takada, M | 1 |
1 other study available for sulfinpyrazone and Nephrosis
| Article | Year |
|---|---|
Protein binding of sulfonamides and displacing effects of sulfinpyrazone on the bound sulfonamides in nephrotic patients in the remissive stage.
Topics: Adolescent; Blood Proteins; Child; Drug Interactions; Female; Humans; Male; Nephrosis; Protein Bindi | 1980 |